Infectious Diseases: Current Epidemiology, Pharmacotherapeutic Strategies, and Global Health Perspectives

Year : 2026 | Volume : 03 | Issue : 01 | Page : 10 18
    By

    Vaibhavi J. Panchal,

  • Hardini P. Chauhan,

  • Hetvi H. Patel,

  • Maitry H. Rathod,

  • Bisojeet R. Khandai,

  1. Student, Department of Pharmacy Practice, Maliba Pharmacy College, Uka Tarsadia University, Bardoli, Gujarat 394350, India
  2. Student, Department of Pharmacy Practice, Maliba Pharmacy College, Uka Tarsadia University, Bardoli, Gujarat 394350, India
  3. Student, Department of Pharmacy Practice, Maliba Pharmacy College, Uka Tarsadia University, Bardoli, Gujarat 394350, India
  4. Student, Department of Pharmacy Practice, Maliba Pharmacy College, Uka Tarsadia University, Bardoli, Gujarat 394350, India
  5. Student, Department of Pharmacy Practice, Maliba Pharmacy College, Uka Tarsadia University, Bardoli, Gujarat 394350, India

Abstract

Infectious diseases are still a major health challenge in the world, and there is increased strain on the health systems of nations. This review examines the most important issues in the management of infectious diseases, such as the distribution and effect of infectious diseases across the world, pharmacotherapeutic approaches, and the functions of public health interventions. New threats such as antimicrobial resistance (AMR), the contribution of climate change, and the unequal representation of healthcare are recognized as significant problems. Individualized medicine, vaccine development, and international cooperation are noted to be potential ways to address the problem of infectious diseases in the future. Another type of strengthening of healthcare infrastructure, the enhancement of surveillance systems, and equal access to treatments and vaccines, are also highlighted in the review. The future studies should aim at exploring the interaction between infectious diseases and the environmental factors, new therapeutics, and improving the global coordination to prevent and contain the outbreak of diseases. This holistic strategy is critical to meeting the emerging trend of infectious diseases

Keywords: Antimicrobial resistance, climate change, disease surveillance, global collaboration, global health, healthcare disparities, infectious diseases, personalized medicine, vaccine development

[This article belongs to Recent Trends in Infectious Diseases ]

How to cite this article:
Vaibhavi J. Panchal, Hardini P. Chauhan, Hetvi H. Patel, Maitry H. Rathod, Bisojeet R. Khandai. Infectious Diseases: Current Epidemiology, Pharmacotherapeutic Strategies, and Global Health Perspectives. Recent Trends in Infectious Diseases. 2026; 03(01):10-18.
How to cite this URL:
Vaibhavi J. Panchal, Hardini P. Chauhan, Hetvi H. Patel, Maitry H. Rathod, Bisojeet R. Khandai. Infectious Diseases: Current Epidemiology, Pharmacotherapeutic Strategies, and Global Health Perspectives. Recent Trends in Infectious Diseases. 2026; 03(01):10-18. Available from: https://journals.stmjournals.com/rtid/article=2026/view=238426


References

  1. Kadiyala KG, Goutham K, Katari NK, Vanipenta Vaccines, diagnosis, and treatment of infectious diseases. In: Sustainable nanomaterials for treatment and diagnosis of infectious diseases. 2025. p. 113–138.
  2. Kumar R, Singh L, Malathi Infected and non-infected diseases detection for human health using surface plasmon resonance biosensors: a review. IEEE Sens J. 2025.
  3. Sirota SB, Bender RG, Dominguez RMV, Movo A, Swetschinski LR, Araki DT, et al. Global burden of lower respiratory infections and aetiologies, 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023. Lancet Infect Dis. 2025.
  4. Nazir A, Nazir A, Zuhair V, Aman S, Sadiq SUR, Hasan AH, et al. The global challenge of antimicrobial resistance: mechanisms, case studies, and mitigation approaches. Health Sci Rep. 2025;8(7):e71077.
  5. Abbasi Immunology of vector-borne diseases: the role of immunopharmacology in controlling viral and parasitic infections. BMC Infect Dis. 2025;25(1):1182.
  6. Kumar V. Solid lipid nanoparticles based drug delivery for major infectious diseases: a narrative review. Next Nanotechnol. 2025;8:100228.
  7. Belay WY, Getachew M, Tegegne BA, Teffera ZH, Dagne A, Zeleke TK, et al. Antimicrobial resistance with a focus on antibacterial, antifungal, antimalarial, and antiviral drug resistance, global priority pathogens, prevention, and control strategies: a review. Ther Adv Infect Dis. 2025;12:20499361251340144.
  8. Mohapatra RK, Mishra S, Kandi V, Sirka CS, Tuglo LS. Emerging and reemerging neglected tropical diseases: epidemiology, transmission, mitigation, and advances in vaccines and chemotherapy. Lausanne: Frontiers Media SA; 2025. p. 1545801.
  9. Aleezada ZN, Patel I, Yusuf N. Understanding HPV-induced cancers and barriers faced by low- and middle-income countries in prevention and treatment. Int J Mol Sci. 2025;26(12):5581.
  10. Maity S, Chowdhary S, Swaminathan A, Ashtaputre N, Mudgal PP, Mukhopadhyay The silent spread of hepatitis E in India—from epidemiological insight to public health action: a comprehensive review. Infection. 2025:1–15.
  11. Dudman S, Zerja A, Hasanoğlu İ, Ruta S, van Welzen B, Nicolini LA, et al. Global vaccination against hepatitis E virus: position paper from the European Society of Clinical Microbiology and Infectious Diseases Viral Hepatitis Study Group. Clin Microbiol Infect. 2025;31(2):201–210.
  12. Berdoy-Webster P. Hard to make and hard to take: exploring current and future barriers to development and implementation of antipoverty vaccines in sub-Saharan Africa. Adv Parasitol. 2025;130:133–160.
  13. Nakhaie M, Shahpar A, Rezaei Zadeh Rukerd M, Farsiu N, Charostad J, Bashash D, et Dengue fever: viral, environmental, and human factors driving expansion and pandemic risk. Rev Med Virol. 2026;36(1):e70088.
  14. Ibrahim B. Immunity and pathogenesis in parasitic infections: molecular basis and applications.
  15. Zhang Y, Jin S, Zuo Z, Liu S, Xu J, Yang C, et Rational design and immunological mechanisms of circular RNA-based vaccines: emerging frontiers in combating pathogen infection. Vaccines. 2025;13(6):563.
  16. Chen S, Dickson DW, Haarith D. Biological control of plant-parasitic nematodes. In: Practical plant Wallingford: CABI; 2025. p. 589–613.
  17. Bhardwaj A, Gupta SP. Introduction to plant mycology and parasitology. In: Exploring the mycology and parasitology of plant life: roots and rivals. 2025. p. 1.
  18. Hossain MM, Sultana F, Mostafa M, Rubayet MT, Mishu NJ, Khan I, et Biological management of soil-borne pathogens through tripartite rhizosphere interactions with plant growth-promoting fungi. Appl Microbiol. 2025;5(4):123.
  19. Falodun MO, Olorunfemi O, Irinoye OO. Infectious diseases: addressing global challenges and prevention strategies for national health improvement. Community Acquir Infect. 2025;12.
  20. Tariq A, Roohi M, Reyaz Enhancing social protection through healthcare access: techniques for preventing infectious diseases and promoting health equity. Int J Curr Microbiol Appl Sci. 2025;14(5):119-131.
  21. Althubaiti A, Alotaibi MS, Alotaibi SHN, Alotaibi F. The role of community health nurses in preventing infectious disease outbreaks: a public health approach. J Med Life Sci. 2025.
  22. Abdoos P. Emerging infectious diseases: strategies for prevention and control. Eurasian J Chem Med Pet Res. 2025;4(1):136-152.
  23. De Gaetano S, Ponzo E, Midiri A, Mancuso G, Filippone D, Infortuna G, et Global trends and action items for the prevention and control of emerging and re-emerging infectious diseases. Hygiene. 2025;5(2):18.
  24. Aslam B, Aljasir Climate change and antimicrobial resistance: interconnected threats and One Health solutions. Antibiotics. 2025;14(9):946.
  25. Sharma M, Akhter MS, Roy S, Srejon R. Future issues in global health: challenges and conundrums. Int J Environ Res Public Health. 2025;22(3):325.
  26. Desai V, Kumar S, Patel B, Patel SN, Patadiya HH, Asawa D, et Navigating antimicrobials and combating antimicrobial resistance: challenges, impacts, and strategies for global action. Cureus. 2025;17(4).
  27. Alhassan MY, Ahmad Antimicrobial resistance in a changing climate: a One Health approach for adaptation and mitigation. Bull Natl Res Cent. 2025;49(1):26.
  28. Eke SM, Cua Invisible engines of resistance: how global inequities drive antimicrobial failure. Antibiotics. 2025;14(7):659.
  29. Cotugno S, De Vita E, Frallonardo L, Novara R, Papagni R, Asaduzzaman M, et Antimicrobial resistance and migration: interrelation between two major global health challenges. Ann Glob Health. 2025;91(1):12.
  30. Singh K, Sahoo GC, Sharma Climate change and antimicrobial resistance. In: Microorganisms resilience to climate change. Cham: Springer; 2025. p. 349–361.
  31. Chiawah JAS. Strengthening vaccine development pipelines to combat emerging infectious diseases and antimicrobial resistance. 2025.
  32. Sah AK, Elshaikh RH, Shalabi MG, Abbas AM, Prabhakar PK, Babker AMA, et al. Role of artificial intelligence and personalized medicine in enhancing HIV management and treatment outcomes. Life. 2025;15(5):745.
  33. Chen Y-M, Hsiao T-H, Lin C-H, Fann Unlocking precision medicine: clinical applications of integrating health records, genetics, and immunology through artificial intelligence. J Biomed Sci. 2025;32(1):16.
  34. Bag AK, Sengupta D. Computational frameworks for zoonotic disease control in Society 5.0: opportunities, challenges, and future research directions. AI Soc. 2025;40(4):2449–2478.
  35. Ogwu MC, Izah Technological innovations in tropical diseases treatment and therapeutics. In: Technological innovations for managing tropical diseases. Cham: Springer Nature Switzerland; 2025. p. 287–308.
Regular Issue Subscription Review Article
Volume 03
Issue 01
Received 01/02/2026
Accepted 02/02/2026
Published 15/02/2026
Publication Time 14 Days
85

Login


My IP

PlumX Metrics